Production (Stage)
WELL Health Technologies Corp.
WELL.TO
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 204.95M | 138.05M | 184.57M | 177.69M | 165.76M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 204.95M | 138.05M | 184.57M | 177.69M | 165.76M |
| Cost of Revenue | 123.10M | 108.64M | 102.27M | 99.22M | 95.94M |
| Gross Profit | 81.85M | 29.40M | 82.30M | 78.47M | 69.83M |
| SG&A Expenses | 65.55M | 54.46M | 56.39M | 55.50M | 59.38M |
| Depreciation & Amortization | 13.62M | 14.98M | 12.81M | 12.65M | 12.28M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 202.26M | 178.08M | 171.47M | 167.37M | 167.60M |
| Operating Income | 2.69M | -40.03M | 13.10M | 10.33M | -1.83M |
| Income Before Tax | -30.04M | -36.28M | -54.74M | 84.05M | 8.41M |
| Income Tax Expenses | -856.30K | -13.61M | 797.00K | -1.43M | -1.81M |
| Earnings from Continuing Operations | -29.19M | -22.67M | -55.54M | 85.49M | 10.22M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -3.27M | 13.38M | -3.99M | -3.84M | -2.07M |
| Net Income | -32.45M | -9.29M | -59.53M | 81.64M | 8.15M |
| EBIT | 2.69M | -40.03M | 13.10M | 10.33M | -1.83M |
| EBITDA | 16.31M | -36.72M | 25.91M | 22.97M | 10.45M |
| EPS Basic | -0.13 | -0.04 | -0.24 | 0.33 | 0.03 |
| Normalized Basic EPS | -0.03 | -0.12 | 0.00 | -0.01 | -0.04 |
| EPS Diluted | -0.13 | -0.05 | -0.24 | 0.31 | 0.03 |
| Normalized Diluted EPS | -0.03 | -0.12 | 0.00 | -0.01 | -0.04 |
| Average Basic Shares Outstanding | 250.49M | 223.82M | 248.80M | 246.05M | 243.13M |
| Average Diluted Shares Outstanding | 250.49M | 223.82M | 248.80M | 262.65M | 253.24M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |